The evaluation of autoantibodies against oxidatively modified low-density lipoprotein (LDL), susceptibility of LDL to oxidation, serum lipids and lipid hydroperoxide levels, total antioxidant status, antioxidant enzyme activities, and endothelial dysfunction in patients with Behçet’s disease
- 31 May 2002
- journal article
- Published by Elsevier in Clinical Biochemistry
- Vol. 35 (3), 217-224
- https://doi.org/10.1016/s0009-9120(02)00290-4
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Superoxide dismutase and myeloperoxidase activity in polymorphonuclear leukocytes, and serum ceruloplasmin and copper levels, in psoriasisBritish Journal of Dermatology, 2006
- Autoantibodies against Oxidatively Modified Low-Density Lipoprotein in Patients with Behçet’s DiseaseDermatology, 1999
- Relationship between lipid peroxidation and disease activity in patients with Behçet's diseaseJournal of Dermatological Science, 1997
- Clinical significance of antibodies against oxidised low density lipoprotein in early RA.Annals Of The Rheumatic Diseases, 1996
- ROLE OF ENDOTHELIUM IN THROMBOSIS AND HEMOSTASISAnnual Review of Medicine, 1996
- Polymorphonuclear leukocyte elastase levels in patients with Behçet's diseaseClinica Chimica Acta; International Journal of Clinical Chemistry, 1995
- Autoantibodies against oxidatively modified low-density lipoproteins in NIDDMDiabetes, 1995
- Atherosclerosis and AutoimmunityClinical Immunology and Immunopathology, 1994
- Autoantibodies against oxidatively-modified LDL in uremic patients undergoing dialysisKidney International, 1994
- Plasma lipoprotein separation by discontinuous density gradient ultracentrifugation in hyperlipoproteinemic patientsBiochemical Medicine, 1983